Global Market Research Group

Bipolar Disorder Albany, New York, May 03, 2017 "Bipolar Disorder - Canada Drug Forecast and Market Analysis to 2024" The Report covers current Industries Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect. Description- ** Summary Bipolar disorder is a mental disorder characterized by periods of mania and depression. The frequency, severity, and pattern of these episodes can vary considerably over time and between individuals, making bipolar disorder one of the most challenging psychiatric disorders to manage. The bipolar disorder market is widely genericized, with additional key brands expected to face patent or data exclusivity expiries during the forecast period. The bipolar disorder market size is anticipated to contract significantly between 2017 and 2024, driven largely by the generic erosion of Otsukas Abilify, the highest selling bipolar disorder product in 2017. The uptake of novel atypical antipsychotic products wi